Rezolute, Inc. (RZLT)
5.00
-0.09
(-1.77%)
USD |
NASDAQ |
Aug 24, 16:00
5.00
0.00 (0.00%)
After-Hours: 20:00
Rezolute Debt to Equity Ratio : 0.0095 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.0095 |
| December 31, 2025 | 0.01 |
| September 30, 2025 | 0.0099 |
| June 30, 2025 | 0.01 |
| March 31, 2025 | 0.0215 |
| December 31, 2024 | 0.0194 |
| September 30, 2024 | 0.0184 |
| June 30, 2024 | 0.0184 |
| March 31, 2024 | 0.0335 |
| December 31, 2023 | 0.0274 |
| September 30, 2023 | 0.0226 |
| June 30, 2023 | 0.0213 |
| March 31, 2023 | 0.0186 |
| December 31, 2022 | 0.0167 |
| September 30, 2022 | 0.0011 |
| June 30, 2022 | 0.0013 |
| March 31, 2022 | 0.2793 |
| December 31, 2021 | 0.2322 |
| September 30, 2021 | 0.6697 |
| June 30, 2021 | 0.5525 |
| March 31, 2021 | 0.0183 |
| December 31, 2020 | 0.0166 |
| September 30, 2020 | 0.0796 |
| June 30, 2020 | 0.0557 |
| March 31, 2020 | 0.0454 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.0358 |
| September 30, 2019 | 0.0281 |
| June 30, 2019 | 0.0057 |
| March 31, 2019 | 0.0022 |
| December 31, 2018 | -0.7435 |
| September 30, 2018 | -0.6421 |
| June 30, 2018 | -0.8671 |
| March 31, 2018 | 1.735 |
| December 31, 2017 | 0.0026 |
| September 30, 2017 | 0.0013 |
| June 30, 2017 | 0.0012 |
| March 31, 2017 | 0.0012 |
| December 31, 2016 | 0.0013 |
| September 30, 2016 | 0.0073 |
| June 30, 2016 | 0.0095 |
| March 31, 2016 | 0.018 |
| December 31, 2015 | 0.0234 |
| September 30, 2015 | 0.0228 |
| June 30, 2015 | 0.0195 |
| March 31, 2015 | 0.0206 |
| December 31, 2014 | 0.0285 |
| September 30, 2014 | 0.0488 |
| June 30, 2014 | 0.0094 |
| March 31, 2014 | 0.2618 |
| December 31, 2013 | -0.8488 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| SELLAS Life Sciences Group, Inc. | 0.0054 |
| AbbVie, Inc. | -11.93 |
| Marker Therapeutics, Inc. | 0.00 |
| Avalo Therapeutics, Inc. | 0.005 |
| Krystal Biotech, Inc. | 0.0065 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 125.46M |
| Total Liabilities (Quarterly) | 8.625M |
| Shareholders Equity (Quarterly) | 116.83M |
| Current Ratio | 15.84 |
| Net Debt Paydown Yield | 0.06% |